Zusammenfassung
In der vorliegenden Übersicht soll deutlich gemacht werden, dass ein vaskuläres Parkinson-Syndrom (VPS) im engeren Sinne eine seltene und klinisch nicht immer von der idiopathischen Parkinson abgrenzbare Erkrankung ist. Im klinischen Sprachgebrauch wird der Terminus VPS allerdings auch für andere Störungsbilder verwendet, die nicht zuletzt aufgrund der unterschiedlichen therapeutischen Implikationen von einem VPS differenziert werden sollten. Die Differenzialdiagnose des VPS umfasst in erster Linie die subkortikale arteriosklerotische Enzephalopathie, bei der eine Parkinson-artige Gangstörung nicht mit weiteren Kardinalsymptomen eines Parkinson-Syndroms verbunden ist sowie die Koexistenz eines neurodegenerativen Parkinson-Syndroms mit einer subkortikalen vaskulären Enzephalopathie. Ein akutes oder subakutes VPS entsteht in der Regel kontralateral zu Hirninfarkten, die den externen Teil des Globus pallidus, den ventrolateralen Teil des Thalamus und (seltener) die Substantia nigra betreffen. Chronische VPS mit schleichendem Beginn entstehen auf dem Boden bilateraler lakunärer subkortikaler Infarkte mit Beeinträchtigung thalamokortikaler Projektionen. Progressionsneigung und Dopa-Responsivität kommen bei akuten und chronischen VPS vor und erschweren die Differenzialdiagnose zu einem degenerativen Parkinson-Syndrom.
Summary
The present review shows that vascular parkinsonian syndrome (VPS) fulfilling stringent diagnostic criteria for parkinsonism is a rare disease that cannot always be distinguished from neurodegenerative parkinsonism on clinical grounds. Thus VPS needs to be differentiated from other disturbances, which have distinct phenomenological and therapeutical features including isolated gait disturbances associated with subcortical arteriosclerotic encephalopathy and neurodegenerative parkinsonism complicated by comorbid vascular encephalopathy. Acute or subacute VPS is usually caused by contralateral infarctions involving the external globus pallidus, ventrolateral thalamus, and, less often, the substantia nigra. Chronic VPS with insidious onset is related to bilateral subcortical infarctions affecting thalamocortical projections. Differentiation from degenerative parkinsonism is difficult in cases of VPS that display a progressive course and response to levodopa.
Literatur
Critchley M (1929) Arteriosclerotic parkinsonism. Brain 52:23–83
Winikates J, Jankovic J (1999) Clinical correlates of vascular parkinsonism. Arch Neurol 56:98–102
Fenelon G, Gray F, Wallays C et al. (1995) Parkinsonism and dilatation of the perivascular spaces (état crible) of the striatum: a clinical, magnetic resonance imaging, and papathological study. Mov Disord 10:754–760
Kim JS (1992) Delayed onset hand tremor caused by cerebral infarction. Stroke 23:292–294
Mark MH, Sage JI, Walters AS et al. (1995) Binswanger’s disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. Mov Disord 10:450–454
Murrow RW, Schweiger GD, Kepes JJ et al. (1990) Parkinsonism due to a basal ganglia lacunar state: clinicopathologic correlation. Neurology 40:897–900
Tolosa ES, Santamaria J (1984) Parkinsonism and basal ganglia infarcts. Neurology 34:1516–1518
Zijlmans JC, Daniel SE, Hughes AJ et al. (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630–640
Sudarsky L (2001) Gait disorders: prevalence, morbidity and etiology. Adv Neurol 87:11–18
Fitzgerald PM, Jankovic J (1989) Lower body parkinsonism: evidence for vascular etiology. Mov Disord 4:249–260
Hughes AJ, Daniel SE, Blankson S et al. (1993) A clinicopathological study of 100 cases of Parkinson’s disease. Arch Neurol 50:140–148
Bathia KP, Marsden CD (1994) The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 117:825–834
Reider-Groswasser I, Bornstein NM, Korczyn AD (1995) Parkinsonism in patients with lacunar infarcts of the basal ganglia. Eur Neurol 35:46–49
Boiten J, Lodder J (1992) Large striatocapsular infarct: clinical presentation and pathogenesis in comparison with lacunar and cortical infarcts. Acta Neurol Scand 86:298–303
Weiller C, Ringelstein EB, Reiche W et al. (1990) The large striatocapsular infarct. A clinical and pathophysiological entity. Arch Neurol 47:1085–1091
Chung CS, Caplan LR, Yamamoto Y et al. (2000) Striatocapsular haemorrhage. Brain 123:1850–1862
Peralta C, Werner P, Holl B et al. (2004) Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort. J Neural Transm 111:1473–1483
Foltynie T, Barker R, Brayne C (2002) Vascular Parkinsonism: a review of the precision and frequency of the diagnosis. Neuroepidemiology 21:1–7
Baloh RW (1995) White matter lesions and disequilibrium in older people. Arch Neurol 52:970–979
Masdeu JC, Wolfson L, Lantos G et al. (1989) Brain white-matter changes in the elderly prone to falling. Arch Neurol 46:1292–1296
Van Zagten M, Lodder J, Kessels F (1998) Gait Disorder and Parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions. Mov Disord 13:89–95
Yamanouchi H, Nagura H (1997) Neurological signs and frontal white matter lesions in vascular parkinsonism. Stroke 28:965–969
Tison F, Duche B, Loiseau P (1993) Vascular hemi-parkinson disease. Rev Neurol 149:565–567
Zijlmans JC, Katzenschlager R, Daniel SE et al. (2004) The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry 75:545–547
Volkmann J (2004) Morbus Parkinson—Indikationen und Auswahl des Zielpunktes. In: Krauss JK, Volkmann J (Hrsg) Tiefe Hirnstimulation. Steinkopff, Darmstadt, S 258–268
Bäzner H, Schanz J, Blahak C et al. (2005) Differential pattern of hand-tapping compromise in vascular versus idiopathic parkinsonism: a study based on computerized movement analysis. Mov Disord 20:504–508
Durif F, Pollak P, Hommel M et al. (1992) Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson’s disease. Eur Neurol 32:32–36
Piccini P, Pavese N, Canapicchi R et al. (1995) White matter hyperintensities in Parkinson’s disease. Arch Neurol 52:191–194
Ebersbach G, Sojer M, Valldeoriola F et al. (1999) Comparative analysis of gait in Parkinson’s disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain 122:1349–1355
Ebersbach G, Sojer M, Müller J et al. (2002) Gleichgewichtsstörungen bei idiopathischer Parkinson-Erkrankung. Nervenarzt 73:162–165
Bonnet AM, Loria Y, Saint-Hilaire MH et al. (1987) Does long-term aggravation of Parkinson’s disease result from nondopaminergic lesions? Neurology 37:1539–1542
Gerschlager W, Bencsits G, Pirker W et al. (2002) [123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson’s disease. Mov Disord 17:518–523
Lorberboym M, Djaldetti R, Melamed E et al. (2004) 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med 45:1688–1693
Katzenschlager R, Zijlmans J, Evans A et al. (2004) Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:1749–1752
Interessenkonflikt
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ebersbach, G., Poewe, W. Das vaskuläre Parkinson-Syndrom. Nervenarzt 77, 139–147 (2006). https://doi.org/10.1007/s00115-005-1978-6
Issue Date:
DOI: https://doi.org/10.1007/s00115-005-1978-6
Schlüsselwörter
- Parkinson
- Vaskuläres Parkinson-Syndrom
- Subkortikale arteriosklerotische Enzephalopathie
- Gangstörung
- Parkinson-Therapie